|
US6329418B1
(en)
|
1998-04-14 |
2001-12-11 |
The Procter & Gamble Company |
Substituted pyrrolidine hydroxamate metalloprotease inhibitors
|
|
US20030017528A1
(en)
*
|
1998-11-20 |
2003-01-23 |
Ruoping Chen |
Human orphan G protein-coupled receptors
|
|
US6221660B1
(en)
*
|
1999-02-22 |
2001-04-24 |
Synaptic Pharmaceutical Corporation |
DNA encoding SNORF25 receptor
|
|
US20040171630A1
(en)
|
2001-06-19 |
2004-09-02 |
Yuntae Kim |
Tyrosine kinase inhibitors
|
|
DE10225574A1
(de)
|
2002-06-10 |
2003-12-18 |
Merck Patent Gmbh |
Aryloxime
|
|
US7342115B2
(en)
|
2002-11-08 |
2008-03-11 |
Neurogen Corporation |
3-substituted-6-aryl pyridines
|
|
HRP20050696B1
(en)
|
2003-01-14 |
2008-10-31 |
Arena Pharmaceuticals Inc. |
1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
|
|
US7083933B1
(en)
*
|
2003-05-09 |
2006-08-01 |
Prosidion Limited |
Methods for identification of modulators of OSGPR116 activity
|
|
AR045047A1
(es)
|
2003-07-11 |
2005-10-12 |
Arena Pharm Inc |
Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
|
|
NZ547965A
(en)
|
2003-12-24 |
2009-12-24 |
Prosidion Ltd |
1,2,4-Oxadiazole derivatives as GPCR receptor agonists
|
|
UA92150C2
(ru)
|
2004-06-04 |
2010-10-11 |
Арена Фармасьютикалз, Инк. |
Замещенные производные арила и гетероарила как модуляторы метаболизма и для профилактики и лечения связанных с ним расстройств
|
|
MX2007007553A
(es)
|
2004-12-24 |
2007-08-15 |
Prosidion Ltd |
Agonistas del receptor acoplado a proteina g (gpr116) y uso de los mismos para tratar obesidad y diabetes.
|
|
US8193359B2
(en)
|
2004-12-24 |
2012-06-05 |
Prosidion Limited |
G-protein coupled receptor agonists
|
|
GB0428514D0
(en)
|
2004-12-31 |
2005-02-09 |
Prosidion Ltd |
Compounds
|
|
DOP2006000008A
(es)
|
2005-01-10 |
2006-08-31 |
Arena Pharm Inc |
Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1
|
|
MY148521A
(en)
|
2005-01-10 |
2013-04-30 |
Arena Pharm Inc |
Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
|
|
EP1841736A1
(en)
|
2005-01-19 |
2007-10-10 |
Biolipox AB |
Indoles useful in the treatment of inflammation
|
|
CA2594773A1
(en)
|
2005-01-19 |
2006-07-27 |
Biolipox Ab |
Indoles useful in the treatment of inflammation
|
|
WO2006077364A1
(en)
|
2005-01-19 |
2006-07-27 |
Biolipox Ab |
Indoles useful in the treatment of inflammation
|
|
JP2008545008A
(ja)
|
2005-06-30 |
2008-12-11 |
プロシディオン・リミテッド |
Ｇｐｃｒアゴニスト
|
|
JP5114395B2
(ja)
|
2005-06-30 |
2013-01-09 |
プロシディオン・リミテッド |
Ｇｐｃｒアゴニスト
|
|
JP2008545009A
(ja)
|
2005-06-30 |
2008-12-11 |
プロシディオン・リミテッド |
Ｇｐｃｒアゴニスト
|
|
US20090203676A1
(en)
|
2005-06-30 |
2009-08-13 |
Oscar Barba |
G-protein Coupled Receptor Agonists
|
|
ATE429430T1
(de)
|
2005-09-16 |
2009-05-15 |
Arena Pharm Inc |
Stoffwechselmodulatoren und behandlung damit verbundener erkrankungen
|
|
RU2008140382A
(ru)
|
2006-03-16 |
2010-04-27 |
Новартис АГ (CH) |
Гетероциклические органические соединения, например, для лечения меланомы
|
|
NZ571869A
(en)
|
2006-04-06 |
2011-11-25 |
Prosidion Ltd |
Heterocyclic GPCR agonists
|
|
PE20071221A1
(es)
|
2006-04-11 |
2007-12-14 |
Arena Pharm Inc |
Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas
|
|
DE602007010420D1
(de)
|
2006-04-11 |
2010-12-23 |
Arena Pharm Inc |
Verfahren zur verwendung des gpr119-rezeptors zur identifizierung von verbindungen zur erhöhung der knochenmasse bei einer person
|
|
GB0607196D0
(en)
|
2006-04-11 |
2006-05-17 |
Prosidion Ltd |
G-protein coupled receptor agonists
|
|
GB0610746D0
(en)
*
|
2006-06-01 |
2006-07-12 |
Prosidion Ltd |
Method of treatment
|
|
TW200811140A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
|
TW200811147A
(en)
|
2006-07-06 |
2008-03-01 |
Arena Pharm Inc |
Modulators of metabolism and the treatment of disorders related thereto
|
|
EP2043744A2
(en)
|
2006-07-13 |
2009-04-08 |
SmithKline Beecham Corporation |
Chemical compounds
|
|
WO2008009924A2
(en)
|
2006-07-18 |
2008-01-24 |
Biolipox Ab |
Indoles useful in the treatment of inflammation
|
|
US20080103141A1
(en)
|
2006-08-30 |
2008-05-01 |
Biovitrum |
New compounds
|
|
EP2094683B1
(en)
|
2006-12-06 |
2011-10-12 |
GlaxoSmithKline LLC |
Bicyclic compounds and use as antidiabetics
|
|
US7638541B2
(en)
|
2006-12-28 |
2009-12-29 |
Metabolex Inc. |
5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
|
|
EA016507B1
(ru)
|
2007-01-04 |
2012-05-30 |
Прозидион Лимитед |
Пиперидиновые агонисты gpcr
|
|
PE20081659A1
(es)
|
2007-01-04 |
2008-10-24 |
Prosidion Ltd |
Agonistas de gpcr
|
|
GB0700122D0
(en)
|
2007-01-04 |
2007-02-14 |
Prosidion Ltd |
GPCR agonists
|
|
CL2008000017A1
(es)
|
2007-01-04 |
2008-08-01 |
Prosidion Ltd |
Compuestos derivados de heterociclos de nitrogeno y oxigeno, agonistas de gpcr; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la obesidad, diabetes, sindrome metabolico, hiperlipidemia, toleranci
|
|
ATE523507T1
(de)
|
2007-01-04 |
2011-09-15 |
Prosidion Ltd |
Piperidin-gpcr-agonisten
|
|
US20080186971A1
(en)
|
2007-02-02 |
2008-08-07 |
Tarari, Inc. |
Systems and methods for processing access control lists (acls) in network switches using regular expression matching logic
|
|
PE20081791A1
(es)
*
|
2007-02-28 |
2009-02-07 |
Eisai Randd Man Co Ltd |
Dos derivados ciclicos de oxomorfolina
|
|
ES2352880T3
(es)
|
2007-03-08 |
2011-02-23 |
Irm Llc |
Compuestos y composiciones como moduladores de la actividad de gpr119.
|
|
EP2141148B1
(en)
|
2007-03-29 |
2013-07-03 |
Daiichi Sankyo Company, Limited |
Indole derivative having cpla2 inhibitory activity, use of the same and method for producing the same
|
|
JP2010526146A
(ja)
|
2007-05-04 |
2010-07-29 |
ブリストル−マイヤーズ スクイブ カンパニー |
［６，５］−二環式ｇｐｒ１１９ｇタンパク質結合受容体アゴニスト
|
|
US7910583B2
(en)
|
2007-05-04 |
2011-03-22 |
Bristol-Myers Squibb Company |
[6,6] and [6,7]-bicyclic GPR119 G protein-coupled receptor agonists
|
|
US7928230B2
(en)
|
2007-07-17 |
2011-04-19 |
Bristol-Myers Squibb Company |
Method for modulating GPR119 G protein-coupled receptor and selected compounds
|
|
EP2185544B1
(en)
|
2007-07-19 |
2014-11-26 |
Cymabay Therapeutics, Inc. |
N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the rup3 or gpr119 for the treatment of diabetes and metabolic disorders
|
|
EP2200609A1
(en)
|
2007-09-10 |
2010-06-30 |
Prosidion Limited |
Compounds for the treatment of metabolic disorders
|
|
BRPI0817211A2
(pt)
|
2007-09-20 |
2017-05-16 |
Irm Llc |
composto composições como moduladores da atividade de gpr119
|
|
NZ585284A
(en)
*
|
2007-10-16 |
2011-03-31 |
Daiichi Sankyo Co Ltd |
Pyrimidyl indoline compounds with hypoglycaemic effect useful in the treatment of diabetes related diseases and adiposity
|
|
GB0720390D0
(en)
|
2007-10-18 |
2007-11-28 |
Prosidion Ltd |
G-Protein coupled receptor agonists
|
|
GB0720389D0
(en)
|
2007-10-18 |
2008-11-12 |
Prosidion Ltd |
G-Protein Coupled Receptor Agonists
|
|
AU2008317057B8
(en)
|
2007-10-22 |
2014-02-13 |
Merck Sharp & Dohme Corp. |
Bicyclic Heterocycle Derivatives and their use as modulators of the activity of GPR119
|
|
US20100261743A1
(en)
|
2007-12-06 |
2010-10-14 |
Glaxosmithkline Llc |
Novel seh inhibitors and their use
|
|
CA2716330A1
(en)
|
2008-02-22 |
2009-08-27 |
Irm Llc |
Compounds and compositions as modulators of gpr119 activity
|
|
AU2009217359B2
(en)
|
2008-02-22 |
2011-09-01 |
Irm Llc |
Compounds and compositions as modulators of GPR119 activity
|
|
WO2009106561A1
(en)
|
2008-02-27 |
2009-09-03 |
Biovitrum Ab (Publ) |
Pyrazine compounds for treating gpr119 related disorders
|
|
WO2009106565A1
(en)
|
2008-02-27 |
2009-09-03 |
Biovitrum Ab (Publ) |
Agonists of gpr119
|
|
WO2009123221A1
(ja)
|
2008-03-31 |
2009-10-08 |
全薬工業株式会社 |
細胞保護作用を有するピリミジン誘導体およびその用途
|
|
CA2719507C
(en)
|
2008-03-31 |
2018-03-27 |
Metabolex, Inc. |
Oxymethylene aryl compounds and uses thereof
|
|
WO2009125434A2
(en)
|
2008-04-07 |
2009-10-15 |
Cadila Healthcare Limited |
Oxime derivatives
|
|
JP2011516557A
(ja)
|
2008-04-07 |
2011-05-26 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Ｇｐｒ１１９活性のモジュレーターとしての化合物および組成物
|
|
US8343990B2
(en)
|
2008-04-14 |
2013-01-01 |
Merck Sharp & Dohme Corp. |
Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
|
|
US8188098B2
(en)
|
2008-05-19 |
2012-05-29 |
Hoffmann-La Roche Inc. |
GPR119 receptor agonists
|
|
WO2009150144A1
(en)
|
2008-06-10 |
2009-12-17 |
Inovacia Ab |
New gpr119modulators
|
|
AU2009271414A1
(en)
|
2008-06-20 |
2010-01-21 |
Metabolex, Inc. |
Aryl GPR119 agonists and uses thereof
|
|
ES2387865T3
(es)
|
2008-07-10 |
2012-10-03 |
Prosidion Ltd |
Agonistas de GPCR de piperidina
|
|
GB0812649D0
(en)
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
|
GB0812642D0
(en)
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
|
GB0812648D0
(en)
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
|
GB0812641D0
(en)
|
2008-07-10 |
2008-08-20 |
Prosidion Ltd |
Compounds
|
|
CN102083813A
(zh)
|
2008-07-10 |
2011-06-01 |
普洛希典有限公司 |
哌啶基gpcr激动剂
|
|
ES2429129T3
(es)
|
2008-07-11 |
2013-11-13 |
Irm Llc |
4-Fenoximetilpiperidinas como moduladores de la actividad de GPR119
|
|
WO2010009195A1
(en)
|
2008-07-16 |
2010-01-21 |
Schering Corporation |
Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
|
|
TW201006821A
(en)
|
2008-07-16 |
2010-02-16 |
Bristol Myers Squibb Co |
Pyridone and pyridazone analogues as GPR119 modulators
|
|
EP2320910A4
(en)
|
2008-07-30 |
2012-12-19 |
Glaxosmithkline Llc |
CHEMICAL COMPOUNDS AND ITS USE
|
|
US8536176B2
(en)
|
2008-08-01 |
2013-09-17 |
Nippon Chemiphar Co., Ltd. |
GPR119 agonist
|
|
WO2010048149A2
(en)
|
2008-10-20 |
2010-04-29 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
WO2010059385A1
(en)
*
|
2008-10-30 |
2010-05-27 |
Janssen Pharmaceutica Nv |
Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidne derivatives useful as gdir agonists
|
|
WO2010059384A1
(en)
*
|
2008-10-30 |
2010-05-27 |
Janssen Pharmaceutica Nv |
Process for the preparation of tri-substituted pyridine and tri-substituted pyrimidine derivatives useful as gdir agonists
|
|
AU2009330208A1
(en)
|
2008-12-23 |
2011-08-04 |
Merck Sharp & Dohme Corp. |
Bicyclic heterocycle derivatives and methods of use thereof
|
|
WO2010075273A1
(en)
|
2008-12-23 |
2010-07-01 |
Schering Corporation |
Bicyclic heterocycle derivatives and methods of use thereof
|
|
EP2382204B1
(en)
|
2008-12-23 |
2018-07-11 |
Merck Sharp & Dohme Corp. |
Pyrimidine derivatives as gpcr modulators for use in the treatment of obesity and diabetes
|
|
ES2403120T3
(es)
|
2008-12-24 |
2013-05-14 |
Cadila Healthcare Limited |
Nuevos derivados de oxima
|
|
WO2010074271A1
(ja)
|
2008-12-26 |
2010-07-01 |
武田薬品工業株式会社 |
糖尿病治療剤
|
|
US20120016119A1
(en)
|
2009-01-22 |
2012-01-19 |
Yasunori Tsuboi |
NOVEL PYRROLO(2,3-d)PYRIMIDINE COMPOUND
|
|
WO2010088518A2
(en)
|
2009-01-31 |
2010-08-05 |
Kalypsys, Inc. |
Heterocyclic modulators of gpr119 for treatment of disease
|
|
WO2010095663A1
(ja)
*
|
2009-02-18 |
2010-08-26 |
武田薬品工業株式会社 |
縮合複素環化合物
|
|
GB0904287D0
(en)
|
2009-03-12 |
2009-04-22 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
|
GB0904285D0
(en)
|
2009-03-12 |
2009-04-22 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
|
GB0904284D0
(en)
|
2009-03-12 |
2009-04-22 |
Prosidion Ltd |
Compounds for the treatment of metabolic disorders
|
|
JP2012520868A
(ja)
|
2009-03-20 |
2012-09-10 |
ファイザー・インク |
３−オキサ−７−アザビシクロ［３．３．１］ノナン
|
|
EP2414348B1
(en)
|
2009-04-03 |
2013-11-20 |
Merck Sharp & Dohme Corp. |
Bicyclic piperidine and piperazine derivatives as gpcr modulators for the treatment of obesity, diabetes and other metabolic disorders
|
|
AR076024A1
(es)
|
2009-04-03 |
2011-05-11 |
Schering Corp |
Derivados de heterociclos biciclicos puenteados y metodos de uso de los mismos
|
|
JP2010265258A
(ja)
*
|
2009-04-15 |
2010-11-25 |
Daiichi Sankyo Co Ltd |
ピリミジルインドリン化合物を含有する医薬組成物
|
|
WO2010119881A1
(ja)
*
|
2009-04-15 |
2010-10-21 |
第一三共株式会社 |
インドリン化合物
|
|
JP2012136439A
(ja)
|
2009-04-24 |
2012-07-19 |
Nippon Chemiphar Co Ltd |
ジアザスピロアルカン誘導体
|
|
JP2012526096A
(ja)
*
|
2009-05-08 |
2012-10-25 |
ファイザー・インク |
Ｇｐｒ１１９調節因子
|
|
US20100285145A1
(en)
*
|
2009-05-08 |
2010-11-11 |
Pfizer Inc |
Gpr 119 modulators
|
|
WO2010128425A1
(en)
|
2009-05-08 |
2010-11-11 |
Pfizer Inc. |
Gpr 119 modulators
|
|
WO2010135506A1
(en)
|
2009-05-20 |
2010-11-25 |
Janssen Pharmaceutica Nv |
Process for the preparation of 4- [6-(6-methanesulfonyl-2-methyl-pyridin-3-ylamino) -5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester
|
|
WO2010135505A2
(en)
|
2009-05-20 |
2010-11-25 |
Janssen Pharmaceutica Nv |
Crystalline forms of 4-[6-(6-methanesulfonyl-2-methylpyridin-3-ylamino)-5-methoxy-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid isopropyl ester
|
|
JP2012528847A
(ja)
|
2009-06-05 |
2012-11-15 |
ファイザー・インク |
Ｇｐｒ１１９調節因子としてのｌ−（ピペリジン−４−イル）−ピラゾール誘導体
|
|
BR112012000831A2
(pt)
|
2009-06-24 |
2019-09-24 |
Boehringer Ingelheim Int |
compostos, composições farmacêuticas e métodos relacionados
|
|
TW201113269A
(en)
|
2009-06-24 |
2011-04-16 |
Boehringer Ingelheim Int |
New compounds, pharmaceutical composition and methods relating thereto
|
|
US8772323B2
(en)
|
2010-05-07 |
2014-07-08 |
Boehringer Ingelheim International Gmbh |
Benzoxazole- and tetrahydrobenzoxazole-substituted pyridazinones as GPR119 agonists
|
|
US9358233B2
(en)
|
2010-11-29 |
2016-06-07 |
Boehringer Ingelheim International Gmbh |
Method for treating acute myeloid leukemia
|
|
UY33805A
(es)
|
2010-12-17 |
2012-07-31 |
Boehringer Ingelheim Int |
?Derivados de dihidrobenzofuranil-piperidinilo, aza-dihidrobenzofuranilpiperidinilo y diaza-dihidrobenzofuranil-piperidinilo, composiciones farmacéuticas que los contienen y usos de los mismos?.
|
|
CN103443097A
(zh)
|
2011-01-21 |
2013-12-11 |
勃林格殷格翰国际有限公司 |
作为gpr119调节剂用于治疗糖尿病、肥胖症以及相关病症的稠合的二氢呋喃化合物
|
|
JP5935154B2
(ja)
|
2011-03-14 |
2016-06-15 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｇｐｒ１１９モジュレーターとしてのｎ−シクロプロピル−ｎ−ピペリジニルベンズアミド
|